Item 8.01. Other Events.

On March 16, 2020, Seelos Therapeutics, Inc. (the "Company") issued a press release announcing the closing of its previously announced underwritten public offering of shares of its common stock. In the offering, the Company sold an aggregate of 7,500,000 shares of its common stock at a public offering price of $0.60 per share. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.


Number     Description

  99.1     Press Release, dated March 16, 2020.



                                     * * *







                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses